The role of the phosphatase and tensin homolog status in predicting pathological complete response to neoadjuvant anti-HER2 therapies in HER2-positive primary breast cancer: A meta-analysis

PURPOSE: The addition of anti-HER2 therapies to neoadjuvant treatment significantly enhances pathological complete response (PCR) rate in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Selecting patients unlikely to benefit from neoadjuvant anti-HER2 therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chi, Guo, Ying, Li, Jiyu, Tian, Xingsong, Duan, Xuening
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380662/
https://www.ncbi.nlm.nih.gov/pubmed/30702584
http://dx.doi.org/10.1097/MD.0000000000014261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380662/
https://www.ncbi.nlm.nih.gov/pubmed/30702584
http://dx.doi.org/10.1097/MD.0000000000014261

Ejemplares similares